Effect of sinomenine on gene expression of the IL-1β-activated human synovial sarcoma

Life Sciences

Volumn 79, Issue 7, 2006, Pages 665-673

  Li, X J ^a   Yue, Patrick Y K ^a   Ha, W Y ^a   Wong, Daisy Y L ^a   Tin, Mandy M Y ^a   Wang, P X ^b   Wong, Ricky N S ^a   Liu, L ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

DNA microarray; Gene expression; Hs701.T; IL 1 ; Sinomenine; Synovial sarcoma

Indexed keywords

DAXX PROTEIN; HEAT SHOCK PROTEIN 27; INTERLEUKIN 16; INTERLEUKIN 1BETA; PLACENTAL GROWTH FACTOR; SINOMENINE; TETRAZOLIUM BLUE; THYMIDINE; TRITIUM;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL ASSAY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG INHIBITION; DRUG STRUCTURE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; HUMAN; HUMAN CELL; INFLAMMATORY INFILTRATE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL SARCOMA; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DNA, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-1; MORPHINANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA; SYNOVIAL MEMBRANE;

EID: 33745253745     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.02.014     Document Type: Article

References (29)

1. Apte R.N., and Voronov E. Interleukin-1-a major pleiotropic cytokine in tumor-host interactions. Seminars in Cancer Biology 12 4 (2002) 277-290
2. Bergers G., and Benjamin L.E. Tumorigenesis and the angiogenic switch. Nature Reviews 3 6 (2003) 401-410
3. Borg A.A., Wynn-Jones C., and Dawes P.T. Synovial sarcoma manifesting as a single joint flare in rheumatoid arthritis. Clinical Rheumatology 12 1 (1993) 89-92
4. Bottomley M.J., Webb N.J., Watson C.J., Holt L., Bukhari M., Denton J., Freemont A.J., and Brenchley P.E. Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clinical and Experimental Immunology 119 1 (2000) 182-188
5. Donnini S., Machein M.R., Plate K.H., and Weich H.A. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas. The Journal of Pathology 189 1 (1999) 66-71
6. Fisher C. Synovial sarcoma. Annals of Diagnostic Pathology 2 6 (1998) 401-421
7. Hua H.R., and Chen X.P. Study on the mechanisms of sinomenine on analgesic and anti-inflammatory actions. Journal of Xi'an Medical University 4 (1989) 346-349
8. Imaizumi S., Morita T., Kobayashi H., Ito T., and Hirata Y. Synovial sarcoma with extended occult period treated as juvenile rheumatoid arthritis: a case report. Journal of Orthopaedic Science 7 5 (2002) 570-573
9. Kok T.W., Yue P.Y.K., Mak N.K., Fan D.T.P., Liu L., and Wong R.N.S. The anti-angiogenic effect of sinomenine. Angiogenesis 8 1 (2005) 3-12
10. Kransdorf M.J. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. American Journal of Roentgenology 164 1 (1995) 129-134
11. Lao Z.Y. Sinomenine combined with methotrexate in treating rheumatoid arthritis cases. Xien Yi Xue 3 (1985) 292-293
12. Liu L., Resch K., and Kaever V. Inhibition of lymphocytes proliferation by the anti-arthritic drug sinomenine. International Journal of Immunopharmacology 16 8 (1994) 685-691
13. Liu L., Riese J., Rasch K., and Kaever V. Impairment of macrophage eicosanoid and nitric oxide production by an alkaloid from Sinomenium acutum. Arzneimittel-Forschung 44 11 (1994) 1223-1226
14. Liu L., Buchner E., Beitze D., Schmidt-Weber C.B., Kaever V., Emmrich F., and Kinne R.W. Amelioration of rat experimental arthritis by treatment with the alkaloid sinomenine. International Journal of Immunopharmacology 18 10 (1996) 529-543
15. Liu L., Han L., Wong D.Y.L., Yue P.Y.K., Ha W.Y., Hu Y.H., Wang P.X., and Wong R.N. Effects of Si-Jun-Zi decoction polysaccharides on cell migration and gene expression in wounded rat intestinal epithelial cells. British Journal of Nutrition 93 1 (2005) 21-29
16. Michaelson J.S., and Leder P. RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX. Journal of Cell Science 116 Pt 2 (2002) 345-352
17. Nomura M., Yamagishi S., Harada S., Yamashima T., Yamashita J., and Yamamoto H. Placenta growth factor (PlGF) mRNA expression in brain tumors. Journal of Neurooncology 40 2 (1998) 123-130
18. Nowell P. Tumor progression: a brief historical perspective. Seminars in Cancer Biology 12 4 (2002) 261-266
19. Park J.E., Chen H.H., Winer J., Houck K.A., and Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. The Journal of Biological Chemistry 269 41 (1994) 25646-25654
20. Sawano A., Takahashi T., Yamaguchi S., Aonuma M., and Shibuya M. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth & Differentiation 7 2 (1996) 213-221
21. Shen, N., Shen, N.P.T., Quoted by Li, S.C., 1596. In Pen-Tsao Kang-Mu 18 (in Chinese) and quoted by Wong, K.C. and Wu, L.T. (1936). In History of Chinese Medicine. 2nd ed, p. 119. National Quarantine Service. Shanghai.
22. Tsuji F., Oki K., Senda T., Horiuchi M., and Mita S. Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium derived cells. Immunology Letters 68 2-3 (1999) 275-279
23. van de Rijn M., Barr F.G., Xiong Q.B., Hedges M., Shipley J., and Fisher C. Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features. The American Journal of Surgical Pathology 23 1 (1999) 106-112
24. Voronov E., Shouval D.S., Krelin Y., Cagnano E., Benharroch D., Iwakura Y., Dinarello C.A., and Apte R.N. IL-1 is required for tumor invasiveness and angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 100 5 (2003) 2645-2650
25. Wada Y., Shimada K., Kimura T., and Ushiyama S. Novel p38 MAP kinase inhibitors R-130823 suppresses IL-6, IL-8 and MMP-13 production in spheroid culture of human synovial sarcoma cell line SW 982. Immunology Letters 101 1 (2005) 50-59
26. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. The FASEB Journal 13 8 (1999) 781-792
27. Yang X., Khosravi-Far R., Chang H.Y., and Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89 7 (1997) 1067-1076
28. Yokota J. Tumor progression and metastasis. Nature 21 3 (2000) 497-503
29. Yue P.Y.K., Wong D.Y.L., Ha W.Y., Fung M.C., Mak N.K., Yeung H.W., Leung H.W., Chan K., Liu L., Fan T.P.D., and Wong R.N.S. Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg1 in vivo and vitro. Angiogenesis 8 3 (2005) 205-216